Giapreza Injection
Product Images NDC 68547-005

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Giapreza (NDC 68547-005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by La Jolla Pharmaceutical Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Giapreza-structure (Giapreza Structure)

Chemical structure diagram of angiotensin II, the active ingredient in Giapreza injection. The image shows the detailed molecular structure with bonds and functional groups clearly illustrated.*

FDA Label Image

Giapreza-forest-plot (Giapreza Forest Plot)

Forest plot chart depicting odds ratios and 95% confidence intervals comparing the efficacy of Giapreza (angiotensin II) injection versus placebo across various patient subgroups. The subgroups include age, gender, race, baseline BMI, geographical location, baseline MAP, APACHE II score, dialysis status, creatinine clearance, ARDS X-ray status, history of ACEI or ARB use, albumin levels, and norepinephrine equivalency. The chart shows the number and percentage of patients in the Giapreza and placebo groups for each category, with most odds ratios favoring Giapreza.*

FDA Label Image

2.5-vial-label (New 2.5 Vial Jpg)

Label for Giapreza (angiotensin II) Injection, 2.5 mg/mL strength, supplied in a single-dose vial for intravenous use. The label includes usage instructions, storage conditions (2°-8°C), manufacturer information (La Jolla Pharmaceutical Company), and a barcode.*

FDA Label Image

2.5-carton-label (New 2.5 Carton Jpg)

Label for Giapreza (angiotensin II) Injection 2.5 mg/mL single-dose vial by La Jolla Pharmaceutical Company. The label includes dosage instructions, storage conditions (refrigerate between 2°C and 8°C), and manufacturing details. It states the vial contains 1 mL and must be diluted prior to intravenous infusion.*

FDA Label Image

0.5-vial-label (0.5 Vial New)

Label for Giapreza (angiotensin II) injection, single-dose vial, 0.5 mg/mL strength. It includes directions to discard any unused portion and storage instructions (2°C to 8°C). Manufactured by La Jolla Pharmaceutical Company in Malvern, MA, with barcodes and lot/expiration fields visible.*

FDA Label Image

0.5-vial-carton-label (0.5 Carton New)

Packaging label for Giapreza (angiotensin II) Injection 0.5 mg/mL single-dose vial. The label indicates it is an intravenous injection supplied by La Jolla Pharmaceutical Company. It includes dosage details, storage instructions to keep refrigerated between 2°C and 8°C, and notes that the vial must be diluted prior to intravenous infusion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.